Cytokines and Apoptosis in the Cardiovascular System, Halle, Germany, 26-27 February, 1998: The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 675-680

  Loppnow, Harald ^a   Werdan, Karl ^a   Reuter, Gunter ^a   Flad, Hans Dieter ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Apoptosis; Cardiomyocytes; Cardiovascular disease; Cytokines; Endothelial cells; Smooth muscle cells

Indexed keywords

CYTOKINE; ENZYME PRECURSOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1; MESSENGER RNA;

APOPTOSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; NONHUMAN; ANIMAL; CARDIOVASCULAR SYSTEM; DROSOPHILA; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CASPASE 1; DROSOPHILA; HUMANS; INTERLEUKIN-1; RNA, MESSENGER;

EID: 0032247322     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. Dinarello C A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095.
2. Larrick J W. 1989. Native interleukin-1 inhibitors. Immunol. Today 10: 61.
3. Arend W P. 1991. Interleukin-1 receptor antagonist. J. Clin. Invest. 88: 1445.
4. Dower S K, Urdal D L. 1987. The interleukin-1 receptor. Immunol. Today 8: 46.
5. Dinarello C A, Clark B D, Puren A J, Savage N, Rosoff P M. 1989. The interleukin-1 receptor. Immunol. Today 10: 49.
6. Colotta F, Dower S K, Sims J E, Mantovani A. 1994. The type II "decoy" receptor: a novel regulatory pathway for interleukin-1. Immunol. Today 15: 562.
7. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R A, Ju G. 1995. Molecular cloning and characterization of a second subunit of the IL-1 receptor complex. J. Biol. Chem. 270: 13757.
8. Parnat P, Garka K E, Bonnert T P, Dower S K, Sims J E. 1996. IL-1Rrp is a novel receptor-like molecule similar to type I interleukin-1 receptor and its homolougs T1/ST2 and IL-1R AcP. J. Biol. Chem. 271: 3967.
9. Fanslow W G, Sims J E, Sassenfeld H, Morrissey P J, Gillis S, Dower S K, Widmer M B. 1990. Regulation of allo-reactivity in vivo by a soluble form of the IL-1 receptor. Science 248: 739.
10. Martin M U, Falk W. 1997. The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur. Cytokine Netw. 8: 5.
11. Alnemri E S, Livingston D J, Nicholson D W, Salvesen G, Thornberry N A, Wong W W, Yuan J. 1996. Human ICE/CED-3 protease nomenclature. Cell 87: 171.
12. Yuan J, Shaham S, Ledoux S, Ellis H M, Horvitz H R. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian ICE. Cell 75: 641.
13. Kayalar C, Ord T, Testa M P, Zhong L T, Bredesen D E. 1996. Cleavage of actin by ICE to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 93: 2234.
14. Enari M, Talanian R V, Wong W W, Nagata S. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723.
15. Friedlander R M, Gagliardini V, Rotello R J, Yuan J. 1996. Functional role of interleukin-1β (IL-1β) in IL-1β-converting enzyme-mediated apoptosis. J. Exp. Med. 184: 717.
16. Cohen G M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326: 1.
17. Zou H, Henzel W J, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans ced-4, participates in cytochrome C-dependent activation of caspase 3. Cell 90: 405.
18. Medzhitov R, Janeway C A Jr. 1998. An ancient system of host defense. Curr. Opin. Immunol. 10: 12.
19. Gay N J, Keith F J. 1991. Drosophila Toll and IL-1 receptor. Nature 351: 355.
20. Pronk G J, Ramer K, Amiri P, Williams L T. 1996. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by reaper. Science 271: 808.
21. Ross R. 1993. The pathogenesis of atherosclerosis. Nature 362: 801.
22. Seta Y, Shan K, Bozkurt B, Oral H, Mann D L. 1995. Basic mechanisms in heart failure: the cytokine hypothesis. J. Card. Fail. 2.
23. Packer M. 1995. Is TNF an important neurohumoral mechanism in chronic heart failure? Circulation 92: 1379.
24. Matsumori A. 1997. Implications of cytokine inhibition for the drug therapy of heart failure. Bio. Drugs. 7: 102.
25. Werdan K. 1998. The activated immune system in congestive heart failure - from dropsy to the cytokine paradigm. J. Intern. Med. 243: 87.
26. Kubota T, Feldman A M, Demetris A J, Koretsky A P, Lemster B H, Slawson S E, Frye C S, McTiernan C F. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res. 81: 627.
27. Okusawa S, Gelfand J A, Ikejima T, Connolly R J, Dinarello C A. 1988. IL-1 induces a shock-like state in rabbits. J. Clin. Invest. 81: 1162.
28. Neumann F J, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A. 1995. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92: 748.
29. Matsumori A, Yamada T, Suzuki H. 1994. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Brit. Heart J. 72: 561.
30. Clinton S K, Fleet J C, Loppnow H, Salomon R N, Clark B, Cannon J G, Shaw A R, Dinarello C A, Libby P. 1991. IL-1 gene expression in rabbit tissue in vivo. Am. J. Pathol. 158: 1005.
31. Shioi T, Sasayama S, Matsushima K, Iwasaki A, Yamada T, Iwanaga Y, Ono K, Inoko M, Kihara Y, Matsumori A. 1997. Increased expression of IL-1 beta and monocyte chemotactic and activating factor/monocyte chemoatractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81: 664.
32. Francis S E, Holden H, Holt C M, Duff G W. 1998. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 30: 215.
33. Loppnow H, Libby P. 1992. Functional significance of human vascular smooth muscle cell-derived IL-1 in paracrine and autocrine regulation pathways. Exp. Cell Res. 198: 283.
34. Müller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K. 1998. Endotoxin and tumor necrosis factor-alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardio-depressant profiles. J. Mol. Cell. Cardiol. 30: 1027.
35. Miossec P, Cavender D, Ziff M. 1986. Production of IL-1 by human endothelial cells. J. Immunol. 136: 2486.
36. Libby P, Ordovas J M, Birinyi L K, Auger K S, Dinarello C A. 1986. Inducible IL-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest. 78: 1432.
37. Loppnow H, Libby P. 1989. Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL-1. Cell. Immunol. 122: 493.
38. Jirik F R, Podor T J, Hirano T, Kishimoto T, Loskutoff D J, Carson D A, Lotz M. 1989. Bacterial LPS and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142: 144.
39. Sironi M, Breviario F, Proserpio P, Biondi A, Vecchi A, van Damme J, Dejana E, Mantovani A. 1989. IL-1 stimulates IL-6 production in EC. J. Immunol. 142: 549.
40. Loppnow H, Libby P. 1990. Proliferating or interleukin-1-activated human vascular smooth muscle cells secrete copious interleukin-6. J. Clin. Invest. 85: 731.
41. Kröncke R, Loppnow H, Flad H D, Gerdes J. 1996. Human follicular dendritic cells and vascular cells produce IL-7. Eur. J. Immunol. 26: 2541.
42. Wang J M, Sica A, Peri G, Walter S, Padura I M, Libby P, Ceska M, Colotta F, Mantovani A. 1991. Expression of monocyte chemotactic protein and IL-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler. Thromb. 11: 1166.
43. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, Dinarello C A. 1994. IL-1 induces IL-8 secretion from EC by a juxtacrine mechanism. Blood 84: 4242.
44. Schönbeck U, Brandt E, Petersen F, Flad H D, Loppnow H. 1995. IL-8 specifically binds to endothelial but not to smooth muscle cells. J. Immunol. 154: 2375.
45. Loppnow H, Bil R, Hirt S, Schönbeck U, Herzberg M, Werdan K, Rietschel E T, Brandt E, Flad H D. 1998. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91: 134.
46. Kranzhöfer R, Clinton S K, Ishii K, Coughlin S R, Fenton J W, Libby P. 1996. Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear cells. Circ. Res. 79: 286.
47. Beasley D, McGuiggin M. 1994. IL-1 activates soluble guanylate cyclase in human vascular SMC through a novel nitric oxide-independent pathway. J. Exp. Med. 179: 71.
48. Palmer J N, Hartogensis W E, Patten M, Fortuin F D, Long C S. 1995. IL-1 induces cardiac myocyte growth but inhibits fibroblast proliferation. J. Clin. Invest. 95: 2555.
49. Beasley D, McGuiggin M E, Dinarello C A. 1995. Human vascular smooth muscle cells produce an intracellular form of IL-1 receptor antagonist. Am. J. Physiol. 269: C961.
50. Boraschi D, Rambaldi A, Sica A, Ghiara P, Colotta F, Wang J M, de Rossi M, Zoia C, Remuzzi G, Bussolino F, Scapigliat G, Stoppacciaro A, Ruco L, Tagliabue A, Mantovani A. 1991. Endothelial cells express the interleukin-1 receptor type I. Blood 78: 1262.
51. Bromme H J, Holtz J. 1996. Apoptosis in the heart: when and why? Mol. Cell. Biochem. 163-164: 261.
52. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. 1997. Myocyte cell death and ventricular remodeling. Curr. Opin. Neph. Hypertens. 6: 169.
53. Levkau B, Herren B, Koyama H, Ross R, Raines E W. 1998. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187: 579.
54. Perlmann H, Maillard L, Krasinski K, Wals K. 1997. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after ballon injury. Circulation 95: 981.
55. Schumann H, Morawiet H, Hakim K, Zerkowski H R, Eschenhagen T, Holtz J, Darmer D. 1997. Alternative splicing of the primary Fas transcript generating soluble fas antagonists is suppressed in the failing human ventricular myocardium. Biochem. Biophys. Res. Comm. 239: 794.
56. Cai W J, Devaux B, Schaper W, Schaper J. 1997. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131: 177.
57. Schönbeck U, Herzberg M, Petersen A, Wohlenberg C, Gerdes J, Flad H D, Loppnow H. 1997. Human vascular smooth muscle cells express interleukin-1β-converting enzyme (ICE), but inhibit processing of the IL-1β precursor by ICE. J. Exp. Med. 185: 1287.
58. Dimmeler S, Händeler J, Galle J, Zeiher A M. 1997. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. Circulation 95: 1760.
59. Geng Y J, Libby P. 1995. Evidence for apoptosis in advanced human atheroma. Colocalization with ICE. Am. J. Pathol. 147: 251.
60. Yaoita H, Ogawa K, Maehara K, Maruyama Y. 1998. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97: 276.